Regenerative Promise: Battling MS by Targeting the Epstein-Barr Virus”
Targeting the Epstein-Barr virus is ushering in a regenerative health revolution for multiple sclerosis, with breakthrough research paving the way for therapies that go beyond symptom control to directly address the root cause of MS. Early clinical trials using adoptive immunotherapy and vaccines to boost immune control over EBV point to a future where regenerative strategies may prevent or even eradicate the disease, offering new hope to millions affected by MS